Literature DB >> 33546300

Resolvin D1 Decreases Severity of Streptozotocin-Induced Type 1 Diabetes Mellitus by Enhancing BDNF Levels, Reducing Oxidative Stress, and Suppressing Inflammation.

Siresha Bathina1,2, Undurti N Das1,3,4.   

Abstract

Type 1 diabetes mellitus is an autoimmune disease characterized by increased production of pro-inflammatory cytokines secreted by infiltrating macrophages and T cells that destroy pancreatic β cells in a free radical-dependent manner that causes decrease or absence of insulin secretion and consequent hyperglycemia. Hence, suppression of pro-inflammatory cytokines and oxidative stress may ameliorate or decrease the severity of diabetes mellitus. To investigate the effect and mechanism(s) of action of RVD1, an anti-inflammatory metabolite derived from docosahexaenoic acid (DHA), on STZ-induced type 1 DM in male Wistar rats, type 1 diabetes was induced by single intraperitoneal (i.p) streptozotocin (STZ-65 mg/kg) injection. RVD1 (60 ng/mL, given intraperitoneally) was administered from day 1 along with STZ for five consecutive days. Plasma glucose, IL-6, TNF-α, BDNF (brain-derived neurotrophic factor that has anti-diabetic actions), LXA4 (lipoxin A4), and RVD1 levels and BDNF concentrations in the pancreas, liver, and brain tissues were measured. Apoptotic (Bcl2/Bax), inflammatory (COX-1/COX-2/Nf-κb/iNOS/PPAR-γ) genes and downstream insulin signaling proteins (Gsk-3β/Foxo1) were measured in the pancreatic tissue along with concentrations of various antioxidants and lipid peroxides. RVD1 decreased severity of STZ-induced type 1 DM by restoring altered plasma levels of TNF-α, IL-6, and BDNF (p < 0.001); expression of pancreatic COX-1/COX-2/PPAR-γ genes and downstream insulin signaling proteins (Gsk-3β/Foxo1) and the concentrations of antioxidants and lipid peroxides to near normal. RVD1 treatment restored expression of Bcl2/Pdx genes, plasma LXA4 (p < 0.001) and RVD1 levels and increased brain, pancreatic, intestine, and liver BDNF levels to near normal. The results of the present study suggest that RVD1 can prevent STZ-induced type 1 diabetes by its anti-apoptotic, anti-inflammatory, and antioxidant actions and by activating the Pdx gene that is needed for pancreatic β cell proliferation.

Entities:  

Keywords:  antioxidants; resolving D1; streptozotocin; type 1 diabetes mellitus

Mesh:

Substances:

Year:  2021        PMID: 33546300      PMCID: PMC7913477          DOI: 10.3390/ijms22041516

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  49 in total

1.  Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus.

Authors:  Y Suresh; U N Das
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2001-01       Impact factor: 4.006

2.  Resolvin D1 Ameliorates Nicotinamide-streptozotocin-induced Type 2 Diabetes Mellitus by its Anti-inflammatory Action and Modulating PI3K/Akt/mTOR Pathway in the Brain.

Authors:  Siresha Bathina; Naveen K V Gundala; Poorani Rhenghachar; Sailaja Polavarapu; Anasuya D Hari; Monika Sadananda; Undurti N Das
Journal:  Arch Med Res       Date:  2020-05-22       Impact factor: 2.235

3.  Arachidonic acid and lipoxinA4 attenuate streptozotocin-induced cytotoxicity to RIN5 F cells in vitro and type 1 and type 2 diabetes mellitus in vivo.

Authors:  Naveen K V Gundala; Vegi G M Naidu; Undurti N Das
Journal:  Nutrition       Date:  2016-10-15       Impact factor: 4.008

4.  BDNF protects pancreatic β cells (RIN5F) against cytotoxic action of alloxan, streptozotocin, doxorubicin and benzo(a)pyrene in vitro.

Authors:  Siresha Bathina; Nanduri Srinivas; Undurti N Das
Journal:  Metabolism       Date:  2016-02-06       Impact factor: 8.694

5.  Arachidonic acid and lipoxin A4 attenuate alloxan-induced cytotoxicity to RIN5F cells in vitro and type 1 diabetes mellitus in vivo.

Authors:  Naveen K V Gundala; Vegi G M Naidu; Undurti N Das
Journal:  Biofactors       Date:  2016-11-15       Impact factor: 6.113

6.  Prostaglandin metabolism in children with diabetes mellitus. I. Plasma prostaglandin E2, F2 alpha, TXB2, and serum fatty acid levels.

Authors:  M Arisaka; O Arisaka; Y Fukuda; Y Yamashiro
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986 Nov-Dec       Impact factor: 2.839

Review 7.  Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.

Authors:  Tsutomu Nakagawa; Michiko Ono-Kishino; Eiji Sugaru; Mitsugu Yamanaka; Mutsuo Taiji; Hiroshi Noguchi
Journal:  Diabetes Metab Res Rev       Date:  2002 May-Jun       Impact factor: 4.876

8.  Longer breastfeeding is an independent protective factor against development of type 1 diabetes mellitus in childhood.

Authors:  Vaiva Sadauskaite-Kuehne; Johnny Ludvigsson; Zilvinas Padaiga; Edita Jasinskiene; Ulf Samuelsson
Journal:  Diabetes Metab Res Rev       Date:  2004 Mar-Apr       Impact factor: 4.876

Review 9.  Immune mechanisms in type 1 diabetes.

Authors:  Maja Wållberg; Anne Cooke
Journal:  Trends Immunol       Date:  2013-09-18       Impact factor: 16.687

10.  Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice.

Authors:  Eric J Grossman; David D Lee; Jing Tao; Raphael A Wilson; Soo-Young Park; Graeme I Bell; Anita S Chong
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more
  10 in total

1.  Resolvin D5 disrupts anxious- and depressive-like behaviors in a type 1 diabetes mellitus animal model.

Authors:  Felipe Fagundes Leão; Ana Paula Farias Waltrick; Waldiceu Aparecido Verri; Joice Maria da Cunha; Janaina Menezes Zanoveli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-07-19       Impact factor: 3.195

Review 2.  Environmental Factors and the Risk of Developing Type 1 Diabetes-Old Disease and New Data.

Authors:  Katarzyna Zorena; Małgorzata Michalska; Monika Kurpas; Marta Jaskulak; Anna Murawska; Saeid Rostami
Journal:  Biology (Basel)       Date:  2022-04-16

Review 3.  Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.

Authors:  Stanislav Kotlyarov; Anna Kotlyarova
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 4.  Metabolic and Metabolomic Insights Regarding the Omega-3 PUFAs Intake in Type 1 Diabetes Mellitus.

Authors:  Carmen Purdel; Anca Ungurianu; Denisa Margina
Journal:  Front Mol Biosci       Date:  2021-12-03

5.  Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones.

Authors:  Bohan Wang; Jingchao Wei; Qi Huangfu; Fei Gao; Lanxin Qin; Jiao Zhong; Jiaming Wen; Zhangqun Ye; Xiaoqi Yang; Haoran Liu
Journal:  Oxid Med Cell Longev       Date:  2022-02-24       Impact factor: 7.310

Review 6.  Arachidonic Acid as Mechanotransducer of Renin Cell Baroreceptor.

Authors:  Undurti N Das
Journal:  Nutrients       Date:  2022-02-10       Impact factor: 5.717

7.  Syntaxin interacts with arachidonic acid to prevent diabetes mellitus.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2022-08-18       Impact factor: 4.315

8.  Resistance Training Improves Beta Cell Glucose Sensing and Survival in Diabetic Models.

Authors:  Gabriela Alves Bronczek; Gabriela Moreira Soares; Carine Marmentini; Antonio Carlos Boschero; José Maria Costa-Júnior
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

Review 9.  Essential Fatty Acids and Their Metabolites in the Pathobiology of Inflammation and Its Resolution.

Authors:  Undurti N Das
Journal:  Biomolecules       Date:  2021-12-14

Review 10.  Molecular biochemical aspects of salt (sodium chloride) in inflammation and immune response with reference to hypertension and type 2 diabetes mellitus.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2021-08-01       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.